Consun Pharmaceutical Group Limited

OTCPK:CPHG.F Stock Report

Market Cap: US$1.8b

Consun Pharmaceutical Group Past Earnings Performance

Past criteria checks 6/6

Consun Pharmaceutical Group has been growing earnings at an average annual rate of 15%, while the Pharmaceuticals industry saw earnings growing at 12.2% annually. Revenues have been growing at an average rate of 13.1% per year. Consun Pharmaceutical Group's return on equity is 22.5%, and it has net margins of 31.5%.

Key information

15.00%

Earnings growth rate

13.94%

EPS growth rate

Pharmaceuticals Industry Growth5.95%
Revenue growth rate13.10%
Return on equity22.51%
Net Margin31.55%
Last Earnings Update31 Dec 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Consun Pharmaceutical Group makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

OTCPK:CPHG.F Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 253,4171,0781,5170
30 Sep 253,3421,0441,4790
30 Jun 253,2671,0091,4410
31 Mar 253,1179601,3630
31 Dec 242,9679101,2850
30 Sep 242,8538731,2480
30 Jun 242,7398361,2110
31 Mar 242,6658101,1830
31 Dec 232,5907851,1550
30 Sep 232,5287591,1240
30 Jun 232,4667341,0930
31 Mar 232,4037081,0780
31 Dec 222,3406831,0620
30 Sep 222,2466601,0080
30 Jun 222,1526369540
31 Mar 222,0986139180
31 Dec 212,0455908820
30 Sep 211,9595658550
30 Jun 211,8745418270
31 Mar 211,8135208010
31 Dec 201,7534997750
30 Sep 201,6532697540
30 Jun 201,553397330
31 Mar 201,641607520
31 Dec 191,728807710
30 Sep 191,8222887620
30 Jun 191,9164967540
31 Mar 191,8804817460
31 Dec 181,8444657380
30 Sep 181,8024487330
30 Jun 181,7604307280
31 Mar 181,7104137160
31 Dec 171,6603967040
30 Sep 171,6013726800
30 Jun 171,5413476560
31 Mar 171,3823275860
31 Dec 161,2233085160
30 Sep 161,0602914540
30 Jun 168962743920
31 Mar 168632623870
31 Dec 158312503820
30 Sep 158142463720
30 Jun 157982423620

Quality Earnings: CPHG.F has high quality earnings.

Growing Profit Margin: CPHG.F's current net profit margins (31.5%) are higher than last year (30.7%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: CPHG.F's earnings have grown by 15% per year over the past 5 years.

Accelerating Growth: CPHG.F's earnings growth over the past year (18.4%) exceeds its 5-year average (15% per year).

Earnings vs Industry: CPHG.F earnings growth over the past year (18.4%) exceeded the Pharmaceuticals industry 6.6%.

Return on Equity

High ROE: CPHG.F's Return on Equity (22.5%) is considered high.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/04/04 21:33
End of Day Share Price 2026/01/05 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Consun Pharmaceutical Group Limited is covered by 5 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Zhuhong ChenChina Merchants Securities (HK) Co., Ltd
null nullCMB International Securities Limited
Wai Ming KongDBS Bank Ltd